CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLAIR | — |
| MICHAEL CORCORAN | — |
Trade (domestic/foreign) TRD
Pharmaceutical market competition
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLAIR | — |
| MICHAEL CORCORAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.